How ProAir RespiClick (Albuterol) Works
ProAir RespiClick works by stimulating beta-2 adrenergic receptors in bronchial smooth muscle, causing relaxation and bronchodilation, which improves airflow in patients with obstructive airway diseases like asthma. 1
Mechanism of Action
ProAir RespiClick contains albuterol, a short-acting beta-2 agonist (SABA) that:
- Stimulates adenyl cyclase, the enzyme that catalyzes formation of cyclic-3',5'-adenosine monophosphate (cyclic AMP) from adenosine triphosphate (ATP) 1
- The increased cyclic AMP mediates bronchial smooth muscle relaxation 1
- Preferentially affects beta-2 adrenergic receptors (which predominate in bronchial smooth muscle) compared to beta-1 receptors 1
- Provides rapid bronchodilation with minimal side effects 2
Pharmacokinetics
- Onset of action: Within 5 minutes after inhalation 2, 1
- Peak effect: 30-60 minutes 2
- Duration of action: 4-6 hours 2
- Absorption: Less than 20% of a single dose is absorbed following nebulizer administration 1
- Metabolism: Not a substrate for cellular uptake processes for catecholamines or catechol-O-methyl transferase, contributing to its longer duration of action compared to isoproterenol 1
- Elimination: Most of the absorbed dose is recovered in urine within 24 hours 1
Clinical Effects
ProAir RespiClick produces:
- Significant improvement in pulmonary function (FEV1) within 5 minutes 1
- Maximum average improvement in pulmonary function at approximately 1 hour 1
- Clinically significant improvement (defined as ≥15% increase in FEV1 over baseline) for 3-4 hours in most patients, and up to 6 hours in some 1
Delivery System Specifics
ProAir RespiClick is a breath-actuated multidose dry powder inhaler (MDPI) that:
- Does not use chlorofluorocarbon (CFC) propellants, which harm the ozone layer 3
- Instead uses hydrofluoroalkane (HFA) propellants, which have no ozone-depleting effects 3
- Delivers the same amount of drug per puff with similar particle size distribution as older CFC-based inhalers 3
Clinical Applications
ProAir RespiClick is indicated for:
- Quick relief of acute asthma symptoms 4
- Prevention of exercise-induced bronchospasm when used 15 minutes before exercise 4
Important Clinical Considerations
- ProAir RespiClick should be used less than daily on average for symptom relief 4
- Increasing use of albuterol (more than twice weekly) for symptom control generally indicates inadequate asthma control and the need for controller medication 2
- Regular use exceeding twice weekly for symptom control (not for prevention of exercise-induced bronchospasm) indicates the need for initiating or intensifying anti-inflammatory therapy 4, 2
Safety Profile
- Side effects are dose-related and more common with systemic (oral/IV) than inhaled administration 5
- Potential side effects include:
Common Pitfalls to Avoid
Overreliance on rescue therapy: Using ProAir RespiClick more than twice weekly for symptom control suggests inadequate asthma management and need for controller medications 2
Improper inhaler technique: Proper technique is essential for effective medication delivery 2
Using for anaphylaxis management: While ProAir RespiClick may provide adjunctive therapy for wheezing during anaphylaxis, it does not replace epinephrine as the primary treatment 2
Oral vs. inhaled administration: Oral albuterol is less potent, has slower onset, and more side effects than inhaled formulations 2
ProAir RespiClick remains a cornerstone of rescue therapy for asthma, though recent evidence suggests that in some patients with inflammatory components, combining with inhaled corticosteroids may be more efficacious 6.